VITAMIN D NOS: 2,567 Adverse Event Reports & Safety Profile
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
2,567
Total FAERS Reports
269 (10.5%)
Deaths Reported
1,029
Hospitalizations
2,567
As Primary/Secondary Suspect
196
Life-Threatening
115
Disabilities
First Report: 1999 · Latest Report: 20250827
What Are the Most Common VITAMIN D NOS Side Effects?
#1 Most Reported
Asthma
646 reports (25.2%)
#2 Most Reported
Dyspnoea
617 reports (24.0%)
#3 Most Reported
Wheezing
600 reports (23.4%)
All VITAMIN D NOS Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Asthma | 646 | 25.2% | 35 | 392 |
| Dyspnoea | 617 | 24.0% | 49 | 350 |
| Wheezing | 600 | 23.4% | 30 | 345 |
| Therapeutic product effect incomplete | 495 | 19.3% | 35 | 332 |
| Drug ineffective | 483 | 18.8% | 47 | 201 |
| Pain | 377 | 14.7% | 37 | 151 |
| Sleep disorder due to a general medical condition | 347 | 13.5% | 30 | 263 |
| Obstructive airways disorder | 309 | 12.0% | 22 | 175 |
| Fatigue | 304 | 11.8% | 28 | 147 |
| Cough | 299 | 11.7% | 4 | 101 |
| Loss of personal independence in daily activities | 286 | 11.1% | 21 | 180 |
| Full blood count abnormal | 282 | 11.0% | 29 | 189 |
| Condition aggravated | 274 | 10.7% | 49 | 148 |
| Gastrooesophageal reflux disease | 271 | 10.6% | 13 | 215 |
| Headache | 270 | 10.5% | 21 | 187 |
| Off label use | 269 | 10.5% | 49 | 121 |
| Pneumonia | 244 | 9.5% | 16 | 121 |
| Malaise | 221 | 8.6% | 14 | 93 |
| Vomiting | 219 | 8.5% | 21 | 58 |
| Drug hypersensitivity | 206 | 8.0% | 28 | 89 |
Who Reports VITAMIN D NOS Side Effects? Age & Gender Data
Gender: 69.9% female, 30.1% male. Average age: 55.6 years. Most reports from: CA. View detailed demographics →
Is VITAMIN D NOS Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2001 | 1 | 0 | 0 |
| 2004 | 2 | 1 | 1 |
| 2006 | 2 | 0 | 1 |
| 2007 | 1 | 0 | 0 |
| 2008 | 1 | 0 | 0 |
| 2009 | 10 | 0 | 1 |
| 2010 | 7 | 0 | 7 |
| 2011 | 12 | 11 | 1 |
| 2012 | 4 | 0 | 0 |
| 2013 | 8 | 1 | 4 |
| 2014 | 8 | 1 | 3 |
| 2015 | 14 | 4 | 5 |
| 2016 | 23 | 0 | 11 |
| 2017 | 28 | 0 | 10 |
| 2018 | 70 | 5 | 30 |
| 2019 | 72 | 10 | 25 |
| 2020 | 84 | 17 | 38 |
| 2021 | 93 | 15 | 34 |
| 2022 | 68 | 12 | 15 |
| 2023 | 56 | 2 | 22 |
| 2024 | 12 | 0 | 4 |
| 2025 | 17 | 2 | 7 |
What Is VITAMIN D NOS Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 1,697 |
| Psoriasis | 50 |
| Vitamin supplementation | 45 |
| Mast cell activation syndrome | 38 |
| Supplementation therapy | 37 |
| Covid-19 | 34 |
| Osteoporosis | 33 |
| Vitamin d deficiency | 28 |
| Multiple sclerosis | 24 |
| Foetal exposure during pregnancy | 16 |
VITAMIN D NOS vs Alternatives: Which Is Safer?
VITAMIN D NOS vs VITAMINS
VITAMIN D NOS vs VOCLOSPORIN
VITAMIN D NOS vs VOGLIBOSE
VITAMIN D NOS vs VOLTAREN
VITAMIN D NOS vs VON WILLEBRAND FACTOR
VITAMIN D NOS vs VON WILLEBRAND FACTOR HUMAN
VITAMIN D NOS vs VONOPRAZAN
VITAMIN D NOS vs VONOPRAZAN FUMURATE
VITAMIN D NOS vs VORAPAXAR
VITAMIN D NOS vs VORASIDENIB
Official FDA Label for VITAMIN D NOS
Official prescribing information from the FDA-approved drug label.